Lineage Therap(IL:LCTX)
ILA 275.60+7.90 (+2.95%)
IL:LCTX
Lineage Therap earnings date
ILA 275.60
At close:+7.90 (+2.95%)
Lineage Therap (LCTX) Q4 2024 Earnings Report
3 Followers
IL:LCTX Q4 2024 EPS Results
- Actual EPS
- -ILA 6.56
- Consensus EPS
- -ILA 9.83
- Beat/Miss
- Beat by +ILA 3.28
- One Year Ago EPS
- -ILA 9.83
IL:LCTX Q4 2024 Revenue Results
- Actual Revenue
- ILA 940.12M
- Expected Revenue
- ILA 531.36M
- Beat/Miss
- Beat by +ILA 408.76M
- YoY Revenue Growth
- +37.36%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 03/10/2025
- Time
- After Close
- Conference Call
- Monday, March 10, 2025
IL:LCTX Upcoming Earnings
Lineage Therap's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
IL:LCTX Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:LCTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -6.56- | 1.31 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -9.51-9.83 | -42.61 | 76.92% (+32.78) | |
| Aug 06, 2026 | 2026 (Q2) | -9.18-9.83 | -42.61 | 76.92% (+32.78) | |
| May 12, 2026 | 2026 (Q1) | -6.56-9.83 | -6.56 | -50.00% (-3.28) | |
| Mar 05, 2026 | 2025 (Q4) | -14.101.31 | -6.56 | 120.00% (+7.87) | |
| Nov 06, 2025 | 2025 (Q3) | -8.52-42.61 | -6.56 | -550.00% (-36.06) | |
| Aug 12, 2025 | 2025 (Q2) | -8.85-42.61 | -9.83 | -333.33% (-32.78) | |
| May 13, 2025 | 2025 (Q1) | -8.52-6.56 | -13.11 | 50.00% (+6.56) | |
| Mar 10, 2025 | 2024 (Q4) | -9.83-6.56 | -9.83 | 33.33% (+3.28) | |
| Nov 14, 2024 | 2024 (Q3) | -13.11-6.56 | -13.11 | 50.00% (+6.56) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

